title: Diagnostic value of exhaled nitric oxide to detect interstitial lung disease in systemic sclerosis.
abstract: OBJECTIVE
  Increased alveolar concentration of nitric oxide (CA(NO)) is related to the severity of interstitial lung disease (ILD) in systemic sclerosis (SSc). However, cut-off levels of CA(NO) to rule out, or to rule in, the presence of ILD in individual patients are unknown. We aimed to assess the validity of CA(NO) for the diagnosis of ILD in SSc and to determine the thresholds of CA(NO) that can be used in clinical practice to predict the likelihood of ILD in SSc.
  
  
  METHODS
  Lung HRCT scan, PFTs and partitioned exhaled NO measurements were performed in 65 consecutive SSc patients. ILD was diagnosed on pulmonary HRCT according to the presence of ground glass or reticular opacities. Diagnostic performance of CANo for ILD diagnosis was assessed using ROC curves.
  
  
  RESULTS
  38 out of 65 SSc patients had ILD. CA(NO), at a cut-off level of 4.3 ppb, had a sensitivity and specificity for the diagnosis of ILD of 87% (95% CI: 77 to 99) and 59% (95% CI: 41 to 78), respectively. The same cut-off level of CA(NO) could detect impairment of gas exchange with a sensitivity and specificity of 78% (95% CI: 67 to 90) and 73% (95% CI: 46 to 99), respectively. Moreover, ILD could be ruled in (positive predictive value > 95%) when CA(NO) > or = 10.8 ppb, and ruled out C(ANO) values < or = 3.8 ppb (negative predictive value > 95%).
  
  
  CONCLUSIONS
  CA(NO) could be a valid non-invasive biological marker of ILD in SSc, and be of use in clinical practice.
authors: Université Paris VI, Pierre et Marie Curie, Faculté de Médecine, Assistance Publique Hôpitaux de Paris, Service de Médecine Interne, Hôpital Saint-Antoine, Paris, France.
authors: K P
authors: KP
authors: Tiev
authors: J
authors: J
authors: Coste
authors: M
authors: M
authors: Ziani
authors: F
authors: F
authors: Aubourg
authors: J
authors: J
authors: Cabane
authors: A T
authors: AT
authors: Dinh-Xuan
mesh_terms: D000328:Adult; D000368:Aged; D015415:Biomarkers / Q000378:metabolism; D001944:Breath Tests; D004452:Echocardiography; D045853:Exhalation; D005260:Female; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009569:Nitric Oxide / Q000378:metabolism*; D011237:Predictive Value of Tests; D011446:Prospective Studies; D011659:Pulmonary Gas Exchange; D012372:ROC Curve; D015203:Reproducibility of Results; D012129:Respiratory Function Tests; D012595:Scleroderma, Systemic / Q000150:complications* / Q000000981:diagnostic imaging / Q000378:metabolism / Q000503:physiopathology; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D014057:Tomography, X-Ray Computed
chemical_list: D015415:Biomarkers; D009569:Nitric Oxide